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POTENTIAL CENTRAL NERVOUS SYSTEM TUMOUR
BIOMARKERS IN BODY FLUIDS OF DOGS
• To review the biomarkers in body fluids (cerebrospinal fluid –
CSF-, blood and urine) of primary central nervous system (CNS)
tumours in humans. 
• To identify which of these biomarkers could be useful for the
diagnosis, prognosis and response to treatment of the most
common primary CNS tumours in dogs.
CSF seems to have the best specificity and sensitivity to look for biomarkers as it is a direct link to the CNS.
MiRNAs may be the best option to improve diagnosis as their presence in CSF might be strongly related to different brain tumours
Due to the easiness of obtaining blood and urine, further studies could be of use to find suitable biomarkers in these fluids for the
monitoring of tumour progression.
Dogs have the highest frequency of brain tumours
among domestic animals, meningiomas and gliomas
most frequently. Both types of tumours are very similar
to human meningiomas and gliomas with respect to
growth factors, receptors, initial cytogenetic
expressions and pathophysiology.
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